Oral Bedtime Melatonin in Critically Ill Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT06156059

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06156059
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06156059. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-01 (anticipated); primary completion 2026-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Oral Bedtime Melatonin in Critically Ill Patients
Acronym
Mel-ICU
Condition
Septic Shock
Condition
Stroke Hemorrhagic
Condition
Strokes Thrombotic
Intervention (Drug)
Oral Bedtime Melatonin
Intervention (Drug)
Placebo suspension or capsule
Lead sponsor
Hospital San Carlos, Madrid (class: other)
Collaborator
Universidad Complutense de Madrid (class: other)

Record details

Record id
cardio:ct-nct06156059
Content hash
28a8ade96e13a4a495e45c425779e4b46977a3c4e2953f6aa374511badb982f7